These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8304791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
    Moreno Sierra J, Maestro de las Casas ML, Ortega Heredia MD, Blanco Jimenez E, Hermida Gutiérrez J, Resel Estévez L.
    Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
    [Abstract] [Full Text] [Related]

  • 4. [Determination of serum SCC antigen in transitional cell carcinoma of the bladder].
    Moreno Sierra J, Maestro de las Casas M, Ortega Heredia MD, Rodríguez Molina J, López Asenjo J, Blanco Jiménez E, Hermida Gutiérrez J, Esteban Fuertes M, Resel Estevez L.
    Actas Urol Esp; 1994 Jan; 18(1):26-8. PubMed ID: 8191942
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H, Yamada H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y.
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [Abstract] [Full Text] [Related]

  • 9. Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.
    Allard P, Fradet Y, Têtu B, Bernard P.
    Clin Cancer Res; 1995 Oct; 1(10):1195-202. PubMed ID: 9815912
    [Abstract] [Full Text] [Related]

  • 10. [A transitional cell carcinoma of the urinary bladder with a high level of serum CA 19-9--a case report].
    Saito B, Ohmuro H, Fujieda J, Yamashiro K.
    Gan No Rinsho; 1990 Aug; 36(9):1063-5. PubMed ID: 2381051
    [Abstract] [Full Text] [Related]

  • 11. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M, Chulia MT, Niveiro M, Aranda I, Mira A, Soria F.
    Anticancer Res; 1999 Aug; 19(4C):3531-7. PubMed ID: 10629648
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM, Joseph A, Jin L, Yao Y, Chau MH, Fuchs A, Gomella L, Hastings H, Goldberg ID, Weiss GH.
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [Abstract] [Full Text] [Related]

  • 20. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC, Lin AT, Chen KK, Chang LS.
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.